https://gregory-ms.com/ Gregory MS * Home * Doctors * Researchers * Patients * Developers * Articles * Clinical Trials * Observatory * Downloads * About * Change log Gregory MS I am a robot that indexes and identifies relevant research and clinical trials for Multiple Sclerosis @GregoryMS_ brunoamaral / gregory Daily information on Multiple Sclerosis For Doctors For Researchers For Patients Latest relevant articles Last Update 29 Sep, 23:29 with 4708 articles, since February 2021. Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion of mesenchymal stem cells in multiple sclerosis patients Cytokine. 2021 Sep 25;148:155706. doi: 10.1016/j.cyto.2021.155706. Online ahead of print. ABSTRACT Multiple sclerosis (MS) is a specific type of chronic immune-mediated disease in which the immune responses are almost run against ... Continue Reading September 29, 2021 pubmed Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-b1 Considerable experimental and clinical evidences have proved that human umbilical cord mesenchymal stem cells (UC-MSCs) transplantation was powerful in systemic lupus erythematosus (SLE) treatment. MSCs could ... Continue Reading September 28, 2021 BioMedCentral Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-kappaB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis Neurotox Res. 2021 Sep 27. doi: 10.1007/s12640-021-00417-y. Online ahead of print. ABSTRACT Multiple sclerosis (MS) is a chronic disorder characterized by reactive gliosis, inflammation, and demyelination. Microglia plays a ... Continue Reading September 28, 2021 pubmed Methylphenidate may improve mental fatigue in individuals with multiple sclerosis: A pilot clinical trial not available Continue Reading September 24, 2021 MS & Rel. Disorders Brief electrical nerve stimulation enhances intrinsic repair capacity of the focally demyelinated central nervous system Neural Regen Res. 2022 May;17(5):1042-1050. doi: 10.4103/ 1673-5374.324848. ABSTRACT Our lab has shown that brief electrical nerve stimulation (ES) has a dramatic impact on remyelination of lysophosphatidyl choline (LPC)-induced ... Continue Reading September 24, 2021 pubmed Cumulative effects of therapies on disability in relapsing multiple sclerosis not available Continue Reading September 24, 2021 Sage Pub Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis Neurotherapeutics. 2021 Sep 22. doi: 10.1007/s13311-021-01104-8. Online ahead of print. ABSTRACT Data regarding effectiveness and safety of ocrelizumab in the post-marking setting are lacking. The aim of our study was to provide ... Continue Reading September 23, 2021 pubmed Dry needling for the treatment of muscle spasticity in a patient with multiple sclerosis: a case report Physiother Theory Pract. 2021 Sep 21:1-7. doi: 10.1080/ 09593985.2021.1978118. Online ahead of print. ABSTRACT BACKGROUND: Spasticity is a common cause of disability in multiple sclerosis (MS), which can negatively affect the ... Continue Reading September 22, 2021 pubmed MicroRNA-7188-5p and miR-7235 regulates Multiple sclerosis in an experimental mouse model Mol Immunol. 2021 Sep 17;139:157-167. doi: 10.1016/ j.molimm.2021.07.002. Online ahead of print. ABSTRACT The short non-coding microRNAs (miRNAs) have emerged as reliable modulators of various pathological conditions including ... Continue Reading September 21, 2021 pubmed 1a,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice Glaucoma is an optic neuropathy characterized by loss of function and death of retinal ganglion cells (RGCs), leading to irreversible vision loss. Neuroinflammation is recognized as one of the causes of glauco... Continue Reading September 16, 2021 BioMedCentral * 1 * 2 * 3 * ... * 16 * * Subscribe to the email digest Doctors and Researchers can receive a weekly summary of relevant research articles. How to subscribe SUPPORTERS * Lisbon Collective FOLLOW * * --------------------------------------------------------------------- Copyright (c) 2021 Bruno Amaral